NYXOAH S.A.NN

NYXOAH S.A.

8.90EURD
−0.44−4.71%
As of today at 14:29 GMT
EUR
No trades
See on Supercharts
Next report date
March 13
Report period
Q4 2024
EPS estimate
−0.47 EUR
Revenue estimate
‪2.03 M‬ EUR
Market capitalization
‪334.24 M‬EUR
−1.72EUR
‪−43.21 M‬EUR
‪4.35 M‬EUR
‪15.52 M‬
Beta (1Y)
1.26
Employees (FY)
146
Change (1Y)
+9 +6.57%
Revenue / Employee (1Y)
Net income / Employee (1Y)

About NYXOAH SA


CEO
Olivier Taelman
Website
Headquarters
Mont-Saint-Guibert
Founded
2009
ISIN
BE0974358906
FIGI
BBG00YM3BLG8
Nyxoah SA is a medical technology company, which engages in the development and commercialization of solutions to treat Obstructive Sleep Apnea (OSA). Its solution platform is based on the Genio system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treat moderate to severe OSA. The company was founded by Robert Taub and Adi Mashiach on July 15, 2009, and is headquartered in Mont-Saint-Guibert, Belgium.
Performance
‪−1,750.00%‬
‪−1,450.00%‬
‪−1,150.00%‬
‪−850.00%‬
‪−550.00%‬
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
‪‪−18.00 M‬‬
‪‪−12.00 M‬‬
‪‪−6.00 M‬‬
‪0.00‬
‪‪6.00 M‬‬
Revenue
Net income
Net margin %
Revenue to profit conversion
Revenue
COGS
Gross profit
Op expenses
Op income
Non-Op income/ expenses
Taxes & Other
Net income
‪‪−18.00 M‬‬
‪‪−12.00 M‬‬
‪‪−6.00 M‬‬
‪0.00‬
‪‪6.00 M‬‬
Revenue
COGS
Gross profit
Expenses & adjustments
Net income
‪‪−18.00 M‬‬
‪‪−12.00 M‬‬
‪‪−6.00 M‬‬
‪0.00‬
‪‪6.00 M‬‬
Debt level and coverage
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
‪‪−15.00 M‬‬
‪0.00‬
‪‪15.00 M‬‬
‪‪30.00 M‬‬
‪‪45.00 M‬‬
Debt
Free cash flow
Cash & equivalents
Earnings
Next:Mar 13, 2025
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
‪−0.52‬
‪−0.39‬
‪−0.26‬
‪−0.13‬
‪0.00‬
Actual
Estimate

No news here

Looks like there's nothing to report right now

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange NYXOAH S.A. stocks are traded under the ticker 5YI.
We've gathered analysts' opinions on NYXOAH S.A. future price: according to them, 5YI price has a max estimate of 17.80 EUR and a min estimate of 11.00 EUR. Watch 5YI chart and read a more detailed NYXOAH S.A. stock forecast: see what analysts think of NYXOAH S.A. and suggest that you do with its stocks.
5YI reached its all-time high on Jul 15, 2021 with the price of 29.04 EUR, and its all-time low was 0.02 EUR and was reached on Dec 21, 2020. View more price dynamics on 5YI chart.
See other stocks reaching their highest and lowest prices.
Yes, you can track NYXOAH S.A. financials in yearly and quarterly reports right on TradingView.
NYXOAH S.A. is going to release the next earnings report on Mar 13, 2025. Keep track of upcoming events with our Earnings Calendar.
5YI earnings for the last quarter are −0.50 EUR per share, whereas the estimation was −0.45 EUR resulting in a −9.17% surprise. The estimated earnings for the next quarter are −0.47 EUR per share. See more details about NYXOAH S.A. earnings.
NYXOAH S.A. revenue for the last quarter amounts to ‪1.27 M‬ EUR, despite the estimated figure of ‪1.34 M‬ EUR. In the next quarter, revenue is expected to reach ‪2.03 M‬ EUR.
5YI net income for the last quarter is ‪−17.06 M‬ EUR, while the quarter before that showed ‪−13.12 M‬ EUR of net income which accounts for −29.98% change. Track more NYXOAH S.A. financial stats to get the full picture.
No, 5YI doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Feb 26, 2025, the company has 146.00 employees. See our rating of the largest employees — is NYXOAH S.A. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. NYXOAH S.A. EBITDA is ‪−49.36 M‬ EUR, and current EBITDA margin is −995.54%. See more stats in NYXOAH S.A. financial statements.
Like other stocks, 5YI shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade NYXOAH S.A. stock right from TradingView charts — choose your broker and connect to your account.